Abbott Laboratories (ABT) Yield on Cost (YOC): 2.75%
The yield on cost (YOC) for Abbott Laboratories (ABT) is 2.75%.
ABT Yield on Cost (YOC) Metrics
YIELD ON COST (YOC)
2.75%
Forward Yield on Cost Projections
If you buy ABT today at the current stock price of $88.81 with a yield of 2.75% and dividends continue to grow at the historical rate (10.4% CAGR), your YOC would be:
Current Yield
2.75%
YOC in 3 Years
3.60%
YOC in 5 Years
4.32%
YOC in 10 Years
6.78%
Interactive Yield on Cost Calculator
Project custom investment returns for Abbott Laboratories (ABT) based on your custom cost basis.
Starting Yield
2.75%
Ending YOC
12.10%
Year 15 Dividend
$10.75
Cum. Dividends Recd.
$88.27
| Year | Projected Div. / Share | YoY Dividend Hike | Yield on Cost (YOC) | Total Dividends Recd. |
|---|---|---|---|---|
| Initial | $2.44 | — | 2.75% | $0.00 |
| Year 1 | $2.69 | +10.39% | 3.03% | $2.69 |
| Year 2 | $2.97 | +10.39% | 3.35% | $5.67 |
| Year 3 | $3.28 | +10.39% | 3.70% | $8.95 |
| Year 4 | $3.62 | +10.39% | 4.08% | $12.57 |
| Year 5 | $4.00 | +10.39% | 4.50% | $16.57 |
| Year 6 | $4.42 | +10.39% | 4.97% | $20.99 |
| Year 7 | $4.87 | +10.39% | 5.49% | $25.86 |
| Year 8 | $5.38 | +10.39% | 6.06% | $31.24 |
| Year 9 | $5.94 | +10.39% | 6.69% | $37.18 |
| Year 10 | $6.56 | +10.39% | 7.38% | $43.74 |
| Year 11 | $7.24 | +10.39% | 8.15% | $50.98 |
| Year 12 | $7.99 | +10.39% | 9.00% | $58.97 |
| Year 13 | $8.82 | +10.39% | 9.93% | $67.79 |
| Year 14 | $9.74 | +10.39% | 10.96% | $77.52 |
| Year 15 | $10.75 | +10.39% | 12.10% | $88.27 |
Yield on Cost (YOC) Formula
Formula: Yield on Cost = Annual Dividend / Original Purchase Price × 100
Inputs shown in the projection:
- Original purchase price.
- Annual dividend per share at the starting point.
- Assumed annual dividend growth rate.
- Projected annual dividend divided by original purchase price.
Note: Forward projections assume dividends continue to grow at the designated growth rate. Actual dividend payments are declared by corporate boards and are subject to change.
Abbott Laboratories Yield on Cost (YOC) Formula & Definition
Yield on Cost shows the dividend yield based on your original purchase price. As dividends grow, your YOC increases even if the market yield stays the same.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Abbott Laboratories Yield on Cost (YOC) FAQ
- What is the yield on cost (YOC) for Abbott Laboratories (ABT)?
- The yield on cost (YOC) for ABT stock is 2.75%.
About Abbott Laboratories
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Robert Ford